HIMS+HERS HERS A DL-0001
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides pres… Read more
HIMS+HERS HERS A DL-0001 (82W) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, HIMS+HERS HERS A DL-0001 (82W) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
HIMS+HERS HERS A DL-0001 - Net Assets Trend (None–None)
This chart illustrates how HIMS+HERS HERS A DL-0001's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for HIMS+HERS HERS A DL-0001 (None–None)
The table below shows the annual net assets of HIMS+HERS HERS A DL-0001 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to HIMS+HERS HERS A DL-0001's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
HIMS+HERS HERS A DL-0001 Competitors by Market Cap
The table below lists competitors of HIMS+HERS HERS A DL-0001 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kanzhun Limited
F:8JN0
|
$4.60 Billion |
|
Zhejiang Longsheng Group Co Ltd
SHG:600352
|
$4.60 Billion |
|
Tianshui Huatian Technology Co Ltd
SHE:002185
|
$4.61 Billion |
|
Kingdee International Software Group Company Limited
PINK:KGDEF
|
$4.61 Billion |
|
Hannon Armstrong Sustainable Infrastructure Capital Inc
NYSE:HASI
|
$4.59 Billion |
|
Flughafen Zürich AG
PINK:UZAPF
|
$4.59 Billion |
|
REC Limited
NSE:RECLTD
|
$4.59 Billion |
|
Arkema S.A
PINK:ARKAF
|
$4.59 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in HIMS+HERS HERS A DL-0001's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares HIMS+HERS HERS A DL-0001's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently HIMS+HERS HERS A DL-0001 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares HIMS+HERS HERS A DL-0001's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $9,244,379,027
- Average return on equity (ROE) among peers: -92.52%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| HIMS+HERS HERS A DL-0001 (82W) | €- | N/A | N/A | $4.59 Billion |
| 26U (26U) | $6.75 Million | -514.32% | 1.08x | $248.33K |
| 27N0 (27N0) | $11.56 Million | -0.93% | 0.00x | $4.66K |
| China Resources Pharmaceutical Group Limited (640) | $90.18 Billion | 4.60% | 1.68x | $940.63 Million |
| CIG WIRELESS (6CW) | $27.09 Million | -110.19% | 3.19x | $56.65 Million |
| Solasia Pharma K.K (9SO) | $1.16 Billion | -167.91% | 0.18x | $34.42 Million |
| Apontis Pharma AG (APPH) | $3.46 Million | -34.21% | 7.59x | $11.70 Million |
| Akebia Therapeutics Inc (AX9) | $635.93 Million | -22.58% | 0.57x | $283.56 Million |
| Biofrontera AG (B8FK) | $-12.89 Million | 0.00% | 0.00x | $3.86 Million |
| AVALA RES (CVJ) | $91.87 Million | -27.32% | 0.11x | $113.22K |
| Deciphera Pharmaceuticals Inc (D05) | $341.69 Million | -52.37% | 0.33x | $2.11 Billion |